Ginsenoside Compound K Attenuates Metastatic Growth of Hepatocellular Carcinoma, which Is Associated with the Translocation of Nuclear Factor-κB p65 and Reduction of Matrix Metalloproteinase-2/9
EXPRESSION
HUMAN HEPATOMA-CELLS
Carcinoma, Hepatocellular
Ginsenosides
610
Mice, Nude
Panax
Antineoplastic Agents
Matrix Metalloproteinase Inhibitors
ACTIVATION
Mice
03 medical and health sciences
Cell Line, Tumor
OSTEOPONTIN
Animals
Humans
Neoplasm Metastasis
Mice, Inbred BALB C
0303 health sciences
Dose-Response Relationship, Drug
Plant Extracts
Liver Neoplasms
INTESTINAL METABOLITE
NF-kappa B
IN-VITRO
CANCER
Matrix Metalloproteinases
APOPTOSIS
3. Good health
SAPONIN
BACTERIA
DOI:
10.1055/s-0030-1250454
Publication Date:
2010-10-27T01:07:44Z
AUTHORS (7)
ABSTRACT
The intestinal metabolite of ginseng saponin, compound K (CK), has various chemopreventive and chemotherapeutic activities, including anti-tumor activity. However, the functional mechanisms through which CK attenuates metastatic growth in hepatocellular carcinoma (HCC) remain unclear. Here, using multiple IN VITRO and IN VIVO models, we reported that CK strongly attenuated colony formation, adhesion, and invasion of HCC cells IN VITRO and dramatically inhibited spontaneous HCC metastatic growth IN VIVO. At the molecular level, immunofluorescence and Western blotting analysis confirmed that inhibition of metastatic growth of HCC induced by CK treatment caused a time-dependent decrease in nuclear NF- κB p65 and a concomitant increase in cytosolic NF- κB p65, indicating that CK suppressed the activation of the NF- κB pathway. Meanwhile, our study showed that the inhibition of matrix metalloproteinase2/9 (MMP2/9) expression caused by CK treatment was associated with NF- κB p65 nuclear export. Taken together, our results not only revealed that NF- κB p65 nuclear export and the reduction of MMP2/9 expression were associated with the metastatic inhibition induced by CK, but also suggested that CK may become a potential cytotoxic drug in the prevention and treatment of HCC.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....